Olaf Hardt
Miltenyi Biotec (Germany)(DE)
Publications by Year
Research Areas
Cancer Cells and Metastasis, Cancer Research and Treatments, CAR-T cell therapy research, Prion Diseases and Protein Misfolding, Cancer Genomics and Diagnostics
Most-Cited Works
- → NeuroD1 induces terminal neuronal differentiation in olfactory neurogenesis(2009)167 cited
- → MACSima imaging cyclic staining (MICS) technology reveals combinatorial target pairs for CAR T cell treatment of solid tumors(2022)124 cited
- → Automated Manufacturing of Potent CD20-Directed Chimeric Antigen Receptor T Cells for Clinical Use(2017)112 cited
- → Characterization of Peptides Released from Mitochondria(2004)96 cited
- → Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenocarcinoma(2021)83 cited
- → The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features(2015)82 cited
- → Identification, isolation and characterization of human LGR5-positive colon adenoma cells(2018)72 cited
- → Comparison between cold plasma, electrochemotherapy and combined therapy in a melanoma mouse model(2013)69 cited
- → Highly sensitive profiling of CD44+/CD24− breast cancer stem cells by combining global mRNA amplification and next generation sequencing: Evidence for a hyperactive PI3K pathway(2012)66 cited
- → A Novel Siglec-4 Derived Spacer Improves the Functionality of CAR T Cells Against Membrane-Proximal Epitopes(2020)41 cited